Journal ArticleOPEN ACCESS

Brentuximab vedotin in the treatment of a patient with refractory H odgkin disease and P roteus syndrome – a case report and discussion

  • Myakova N
  • Smirnova N
  • Evstratov D
  • et al.
Clinical Case Reports (2015) 3(7) 646-649
DOI: 10.1002/ccr3.297
N/ACitations
Citations of this article
16Readers
Mendeley users who have this article in their library.

This article is free to access.

Abstract

Treatment of patients with refractory Hodgkin lymphoma is a significant issue. We report a patient with Proteus syndrome and relapsed Hodgkin lymphoma, whose remission was finally achieved after brentuximab vedotin therapy, allowing her to receive a haploidentical stem cell transplant. The possible relationship between both disorders was discussed.

Cite

CITATION STYLE

APA

Myakova, N., Smirnova, N., Evstratov, D., Abugova, Y., Balashov, D., Diakonova, Y., … Maschan, A. (2015). Brentuximab vedotin in the treatment of a patient with refractory H odgkin disease and P roteus syndrome – a case report and discussion. Clinical Case Reports, 3(7), 646–649. https://doi.org/10.1002/ccr3.297

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free